Literature DB >> 21273656

Chronic ecstasy use increases neurotrophin-4 gene expression and protein levels in the rat brain.

Homeira Hatami1, Mohammad Ali Hossainpour-Faizi, Maryam Azarfarin, Parvin Azarfam.   

Abstract

Ecstasy is a widely abused psychoactive recreational drug that is known to induce neuroplastic effects. The molecular basis of addiction remains poorly understood, but diverse lines of evidence suggest that neurotrophins (BDNF, NT-3 and NT-4) play a role in the regulation of synaptic plasticity. The present study was designed to evaluate the alteration of NT-4 protein levels and gene expression in the brain stem, cerebellum and cerebral hemisphere of rat brains in the context of ecstasy dependence. Ecstasy addiction was induced by intraperitoneal injection of ecstasy (10 mg/kg) for 5 days. After chronic ecstasy treatment, the NT-4 levels in the abovementioned areas of the brain were determined by ELISA. There was a significant increase in the NT-4 protein concentration in the brain stem, cerebellum and cerebral hemisphere when compared with control group. Additionally, these regions were assayed for the transcription of NT-4 using semi-quantitative RT-PCR normalized to β-actin gene transcription. The results show that chronic administration of ecstasy significantly increased NT-4 gene expression in the abovementioned areas of brain. The current work demonstrates that ecstasy induced-maladaptations may be regulated by NT-4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21273656     DOI: 10.1016/s1734-1140(10)70361-3

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  1 in total

1.  Transcriptional expression study in the central nervous system of rats: what gene should be used as internal control?

Authors:  Ana Carolina de Moura; Virgínia Meneghini Lazzari; Grasiela Agnes; Silvana Almeida; Márcia Giovenardi; Ana Beatriz Gorini da Veiga
Journal:  Einstein (Sao Paulo)       Date:  2014-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.